Effect of losartan on muscle sympathetic activity and baroreceptor function in systemic hypertension.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  American Journal of Cardiology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.AMJCARD.2004.08.079PMID 15619411
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Losartan Reduces Central and Peripheral Sympathetic Nerve Activity in a Rat Model of Neurogenic Hypertension

  2002cited by this paper
• Effects of Chronic Calcium Channel Blockade on Sympathetic Nerve Activity in Hypertension

  2002cited by this paper
• From the HOPE to the ONTARGET and the TRANSCEND studies: challenges in improving prognosis.

  2002cited by this paper
• Baroreflex Sensitivity and Heart Rate Variability in the Identification of Patients at Risk for Life-Threatening Arrhythmias: Implications for Clinical Trials

  2001cited by this paper
• Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.

  2000cited by this paper
• Losartan reduces sympathetic nerve outflow from the brain of rats with chronic renal failure

  2000cited by this paper
• How to measure baroreflex sensitivity: from the cardiovascular laboratory to daily life

  2000cited by this paper
• Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

  2000cited by this paper
• ANGIOTENSIN II BLUNTS, WHILE AN ANGIOTENSIN‐CONVERTING ENZYME INHIBITOR AUGMENTS, REFLEX SYMPATHETIC INHIBITION IN HUMANS*

  1999cited by this paper
• Effects of chronic ACE inhibition on sympathetic nerve traffic and baroreflex control of circulation in heart failure.

  1997cited by this paper
• Biochemical effects of losartan, a nonpeptide angiotensin II receptor antagonist, on the renin-angiotensin-aldosterone system in hypertensive patients.

  1995cited by this paper
• Somatosensory, proprioceptive, and sympathetic activity in human peripheral nerves.

  1979cited by this paper
• Manoeuvres affecting sympathetic outflow in human muscle nerves.

  1972cited by this paper
• General characteristics of sympathetic activity in human muscle nerves.

  1972cited by this paper
• General characteristics of sympathetic activity in human skin nerves.

  1972cited by this paper

• The Role of Angiotensin Receptor Blockers in the Personalized Management of Diabetic Neuropathy

  2022cites this paper
• Effects of losartan and allopurinol on cardiorespiratory regulation in obstructive sleep apnoea

  2018cites this paper
• Muscle sympathetic nerve activity and volume-regulating factors in healthy pregnant and nonpregnant women.

  2017cites this paper
• Neuroendocrine and Inflammatory Responses to Losartan and Continuous Positive Airway Pressure in Patients with Hypertension and Obstructive Sleep Apnea. A Randomized Controlled Trial.

  2016cites this paper
• Sympathetic activation secondary to chronic kidney disease: therapeutic target for renal denervation?

  2014cites this paper
• Vasoconstriction vascular effects Insulin resistance Kidney injury / ischemia Hypertrophy Arrhythmia Oxygen consumption Renal afferent nerves h Renin release g RAS activation h Sodium retention i Renal blood flow h Proteinuria h Glomerulosclerosis

  2014cites this paper
• Renin–angiotensin and sympathetic nervous system contribution to high blood pressure in Schlager mice

  2011cites this paper
• Neural mechanisms of sympathetic activation during hyperinsulinemia and obesity-induced hypertension

  2010cites this paper
• Baroreceptor reflex is suppressed in rats that develop hyperalgesia behavior after nerve injury

  2009cites this paper
• Is kidney ischemia the central mechanism in parallel activation of the renin and sympathetic system?

  2009cites this paper
• Clinical studies evidencing increased activities of the renin – angiotensin – aldosterone and sympathetic nervous systems in chronic kidney disease

  2009cites this paper
• Efeitos cardiovasculares induzidos por antagonistas angiotensinérgicos no bulbo ventrolateral de ratos com hipertensão renovascular.

  2008cites this paper
• Whole body norepinephrine kinetics in ANG II-salt hypertension in the rat.

  2008cites this paper
• Sympathetic Hyperactivity in Hypertensive Chronic Kidney Disease Patients Is Reduced During Standard Treatment

  2007cites this paper
• Angiotensin II‐based hypertension and the sympathetic nervous system: the role of dose and increased dietary salt in rabbits

  2007cites this paper
• Chronic Low-Dose Angiotensin II Infusion Increases Venomotor Tone by Neurogenic Mechanisms

  2006cites this paper
• Nitric Oxide in Hypertension

  2006cites this paper
• Diagnosis and Treatment of Syncope

  2006cites this paper
• Angiotensin–sympathetic system interactions in cardiovascular and metabolic disease

  2006cites this paper
• Manifestations , Consequences , and Treatment Cardiovascular Autonomic Neuropathy Due to Diabetes Mellitus : Clinical

  2005cites this paper
• Cardiovascular autonomic neuropathy due to diabetes mellitus: clinical manifestations, consequences, and treatment.

  2005cites this paper